Basilea Pharmaceutica – executive interview

Basilea Pharmaceutica – executive interview

Basilea Pharmaceutica — 10 videos in collection

More on this equity

Basilea Pharmaceutica, a Switzerland-based commercial-stage biotech company, specialises in developing innovative treatments for infectious diseases. In this video, CEO David Veitch highlights the urgent need for new therapies to combat severe bacterial and fungal infections. He also discusses the company’s global commercial strategy and the compelling investment opportunity it presents. With a market capitalisation of CHF540m, Basilea is positioned at the forefront of addressing critical healthcare challenges.

Basilea Pharmaceutica will be attending the JP Morgan Healthcare Conference in San Francisco on January 14–15. Don’t miss the chance to connect—book your meeting now here!


You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free